Xin Wei Wang

Active 1988–2026

Also published as
Xin-Wei Wang · Xin‐Wei Wang
241
Papers
37,932
Citations
106
h-index
202
i10-index

Citations

Citations per year for Xin Wei Wang1979: 5 citations1986: 1 citations1987: 1 citations1990: 1 citations1991: 3 citations1992: 3 citations1993: 3 citations1994: 4 citations1995: 38 citations1996: 71 citations1997: 89 citations1998: 83 citations1999: 156 citations2000: 194 citations2001: 198 citations2002: 208 citations2003: 207 citations2004: 193 citations2005: 143 citations2006: 160 citations2007: 152 citations2008: 183 citations2009: 208 citations2010: 340 citations2011: 374 citations2012: 381 citations2013: 412 citations2014: 331 citations2015: 357 citations2016: 259 citations2017: 313 citations2018: 324 citations2019: 1,174 citations2020: 1,494 citations2021: 1,500 citations2022: 1,190 citations2023: 1,086 citations2024: 1,681 citations2025: 950 citations2026: 26 citations1980–1985: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,510 citing papers, 26.7% of this breakdownUnited States: 3,916 citing papers, 23.2% of this breakdownGermany: 768 citing papers, 4.6% of this breakdownUnited Kingdom: 700 citing papers, 4.2% of this breakdownItaly: 661 citing papers, 3.9% of this breakdownJapan: 611 citing papers, 3.6% of this breakdownFrance: 475 citing papers, 2.8% of this breakdownSouth Korea: 426 citing papers, 2.5% of this breakdownSpain: 378 citing papers, 2.2% of this breakdownCanada: 338 citing papers, 2% of this breakdownIndia: 311 citing papers, 1.8% of this breakdownHong Kong: 267 citing papers, 1.6% of this breakdown
0%26.7%Other 20.9%

Fields

  • Medicine44.3%
  • Biochemistry, Genetics and Molecular Biology43.3%
  • Immunology and Microbiology5.7%
  • Engineering1.2%
  • Neuroscience0.8%
  • Environmental Science0.8%
  • Other3.9%

Topics

  • MicroRNA in disease regulation3.5%
  • Hepatocellular Carcinoma Treatment and Prognosis3%
  • Cancer-related molecular mechanisms research2.7%
  • RNA modifications and cancer2.5%
  • Cancer-related Molecular Pathways2.5%
  • Cancer Immunotherapy and Biomarkers2.3%
  • Other83.5%

Coauthors

All papers

Open in search
  1. Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science 2018 cited by 1,511

  2. Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 891

  3. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

    Authors: , , , , , , , - Nature Cancer 2022 cited by 485

  4. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 384

  5. Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

    Authors: , , , , , , , , , , , , , - Cancer Cell 2016 cited by 584

  6. Biomarkers for immunotherapy of hepatocellular carcinoma

    Authors: , , , , , , , - Nature Reviews Clinical Oncology 2023 cited by 198

  7. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ji‐Man Kang, Kesha Oza, Mathuros Ruchirawat, Alexander Kroemer, Xin Wei Wang, Manfred Claassen, Firouzeh Korangy, Tim F. Greten - Cell 2023 cited by 192

  8. Stiff matrix induces exosome secretion to promote tumour growth

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2023 cited by 226

  9. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tim F. Greten - Cancer Discovery 2020 cited by 245

  10. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , - Nature Communications 2021 cited by 237

  11. A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

    Authors: , , , , , , , , , , - Cancer Research 2010 cited by 1,093

  12. Immunology and immunotherapy of cholangiocarcinoma

    Authors: , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 cited by 181

  13. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 158

  14. Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2023 cited by 93

  15. Necroptosis microenvironment directs lineage commitment in liver cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2018 cited by 424

  16. Deep whole-genome analysis of 494 hepatocellular carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongyang Wang - Nature 2024 cited by 128

  17. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natsuko Hama, Tatsuhiro Shibata, Robert H. Wiltrout, Curtis C. Harris, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang - Cancer Cell 2017 cited by 475

  18. EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2008 cited by 1,150

  19. Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 143

  20. Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , - Hepatology 2018 cited by 365

  21. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xin Wei Wang, Hidewaki Nakagawa, Mu‐Sheng Zeng, Fan Bai, Ning Zhang - Cancer Cell 2019 cited by 298

  22. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances

    Authors: , , , , , , - Hepatology 2018 cited by 342

  23. MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression

    Authors: , , , , , , , , , - Gut 2023 cited by 78

  24. The significance of intertumor and intratumor heterogeneity in liver cancer

    Authors: , , - Experimental & Molecular Medicine 2018 cited by 243